EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel TSPO Ligand 2-Cl-MGV-1 Can Counteract Lipopolysaccharide Induced Inflammatory Response in Murine RAW264.7 Macrophage Cell Line and Lung Models

Fadi Obeid, Meygal Kahana, Baraah Dahle, Sheelu Monga iD, Yaniv Zohar, Abraham Weizman iD, Moshe Gavish

Cells · 2024

DOI: 10.3390/cells13201702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Fadi Obeid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel. Hauptthemen laut MEDLINE: Lipopolysaccharides, Mice, Inbred C57BL, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We assessed the anti-inflammatory activity of the TSPO ligand 2-Cl-MGV-1. Lipopolysaccharide (LPS) was used to induce inflammatory response in a murine RAW264.7 macrophage model (LPS: 100 ng/mL) and a mouse model (C57BL/6) of lung inflammation (LPS: 5 mg/kg). In the macrophage model, the presence of 2-Cl-MGV-1 (25 µM) caused the LPS-induced elevation in nitrite levels to decrease by 70% (p < 0.0001) and interleukin (IL)-6 by 50% (p < 0.05). In the mouse model, 2-Cl-MGV-1, administered 30 min before, or co-administered with, an LPS injection, significantly inhibited the elevation in serum IL-5 levels (both by 65%; p < 0.001 and p < 0.01, respectively). 2-Cl-MGV-1 administration to mice 30 min before LPS injection and 1 h thereafter significantly inhibited the elevation in IL-1β serum levels (both by 63%, p < 0.005). IL-6 elevation was inhibited by 73% (p < 0.005) when 2-Cl-MGV-1 was administered 30 min before LPS, by 60% (p < 0.05) when co-administered with LPS, and by 64% (p < 0.05) when administered 1 h after LPS. All cytokine assessments were conducted 6 h post LPS injection. Histological analyses showed decreased leukocyte adherence in the lung tissue of the ligand-treated mice. 2-Cl-MGV-1 administration 30 min prior to exposure to LPS inhibited inflammation-induced open field immobility. The beneficial effect of 2-Cl-MGV-1 suggests its potential as a therapeutic option for inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesMice, Inbred C57BLMacrophagesAnimalsMiceRAW 264.7 CellsLungDisease Models, AnimalLigandsMaleInflammationReceptors, GABAPneumoniaAnti-Inflammatory AgentsCytokines

Stichwörter der Autor:innen

2-Cl-MGV-1RAW264.7 macrophagescytokinesinflammatory responselipopolysaccharide (LPS)translocator protein (TSPO)

Substanzen

LipopolysaccharidesBzrp protein, mouseLigandsReceptors, GABAAnti-Inflammatory AgentsCytokines

Autor:innen und Institutionen

  • Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 31096, Israel.
  • Institute of Pathology and Cytology, Rambam Health Care Campus, P.O. Box 9602, Haifa 3109601, Israel.
  • Laboratory of Biological and Molecular Psychiatry, Felsenstein Medical Research Center, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Research Unit, Geha Mental Health Center, Petah Tikva 4910002, Israel.

ORCID-Profile: Sheelu Monga, Abraham Weizman

Zitieren

APA

Obeid, F., Kahana, M., Dahle, B., Monga, S., Zohar, Y., Weizman, A., & Gavish, M. (2024). Novel TSPO Ligand 2-Cl-MGV-1 Can Counteract Lipopolysaccharide Induced Inflammatory Response in Murine RAW264.7 Macrophage Cell Line and Lung Models. Cells. https://doi.org/10.3390/cells13201702

Vancouver

Obeid F, Kahana M, Dahle B, Monga S, Zohar Y, Weizman A, et al. Novel TSPO Ligand 2-Cl-MGV-1 Can Counteract Lipopolysaccharide Induced Inflammatory Response in Murine RAW264.7 Macrophage Cell Line and Lung Models. Cells. 2024. doi:10.3390/cells13201702

BibTeX
@article{Obeid2024,
  author = {Obeid, Fadi and Kahana, Meygal and Dahle, Baraah and Monga, Sheelu and Zohar, Yaniv and Weizman, Abraham and Gavish, Moshe},
  title = {Novel TSPO Ligand 2-Cl-MGV-1 Can Counteract Lipopolysaccharide Induced Inflammatory Response in Murine RAW264.7 Macrophage Cell Line and Lung Models},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13201702}
}
Kostenlos starten →